Abstract Submission is Now Closed.
Call for Abstracts – Online Submission Only
Are you at the forefront of innovation in bone marrow transplantation and cellular therapies? We invite researchers, clinicians, and industry experts to submit their abstracts for the upcoming ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2024 in Abu Dhabi, United Arab Emirates.
Key Topics Include:
- Hematopoietic Stem Cell Transplantation (HSCT)
- CAR-T Cell Therapy
- Immunotherapy and Graft-versus-Host Disease (GvHD)
- Advances in Gene and Cellular Therapies
- Stem Cell Biology and Regenerative Medicine
- Novel Therapeutics and Clinical Trials
Research Reports
Abstracts must contain original scientific data collected by the author(s). All reports must be based on work that has already been completed. No studies “in progress” will be accepted. Any established research design or method may be used.
Language:
Abstracts must contain original scientific data collected by the author(s). All reports must be based on work that has already been completed. No studies “in progress” will be accepted. Any established research design or method may be used.
Submission:
All abstracts must be submitted via the abstract portal on the website. This should be limited to a maximum of 300 words and should include the following:
- Title of abstract
- Names and contact details of author(s) {organization, city /country, email, phone numbers, fax numbers and mailing address}. Please provide a 50-word biography of the presenting author with your abstract.
- The abstract must include the following headings clearly: Introduction and Background, Methods, Results, Discussion, Conclusion, and References (Please provide evidence of ethical approval and funding acknowledgements if any).
- You will be notified of receipt of your abstract by email. If you do not receive an email within few hours of submission or have any additional queries please contact, email: Congress Email
Important Dates:
Submission Deadline: September 26th, 2024.
Abstract acceptance notification- October 21st, 2024.
Selection Criteria
Abstracts will be evaluated through a blind review process and scored based upon the following criteria:
- Relevance to the congress topics.
- Scientific merit of research (including methodological rigor and contemporary contribution to knowledge).
- Quality, clarity, and completeness of abstracts.
Once your abstract is accepted as an oral, poster or video presentation, the secretariat will contact you for further information and instruction.
*If you have any problem submitting your abstract through the online system, please contact the Secretariat at for assistance.
Terms and Conditions:
- The Scientific Committee reserves the right to make the final decision about the abstract acceptance and its scheduling into the program based on topics and time constraints.
- The language of the conference is English.
- Each abstract submission must indicate if the material was published or presented in any prior conferences or if it received any awards.
- All presenters must register to attend the congress.
- A certificate of appreciation will be given to all the presenters to honor their presentation.
- A certificate of appreciation will be given to all the presenters to honor their presentation.
Declaration Text:
By submitting this abstract, I agree to grant and assign to the ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2024 all rights, including copyright, in the presentation listed below, as well as any related materials used for audiovisual presentation (collectively referred to as “the works”). I also grant and assign to the ADSCC Congress 2024 the rights to film, record, reproduce, reprint, and otherwise utilize the works, or any presentation of the works, in any media or format. Furthermore, I authorize the ADSCC Congress 2024 to use my name, likeness, photograph, and biographical data in connection with its use and promotion of the works. I understand that I will receive no royalty or other monetary compensation from the ADSCC Congress 2024 for this assignment of rights and the subsequent use of my works by the Congress.
I represent and warrant that the works are my original creation or that I have obtained all necessary permissions and authorizations from any individuals or entities that may otherwise have a right, title, or interest in the works. I affirm that I have full legal authority to make this assignment and that the works do not infringe upon any copyright, proprietary rights, personal rights, or human rights of others. I further warrant that the works are factually accurate and contain no content that is libelous or otherwise unlawful under UAE law.
I also acknowledge that I am solely responsible for any legal issues arising from my submitted works and any actions taken as a result. I agree to bear all related expenses for travel to Abu Dhabi for the congress, and I understand that these costs will not be covered by the ADSCC 2024 Scientific Committee.